Taiwan FDA registration 8dfdd80abb23d42cdaba666f73b23917

Bondis Human Antistreptolysin O Set (Unsterilized)

TW: 邦迪斯人類抗鏈球菌溶血素O套組(未滅菌)
Taiwan flagTaiwan·Risk Class 1·THE BINDING SITE GROUP LTD·Registered Jan 13, 2020 – Jan 13, 2030Active
Registration details
Analysis ID
8dfdd80abb23d42cdaba666f73b23917
Customs Code
DHA09402118301
Company information
Manufacturer Country
United Kingdom
Authorized Representative
EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
Intended Use
Classification and grading management method for medical devices: Streptococcus is an extracellular enzyme reagent (C.3720) in the first grade identification range.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3720 鏈球菌屬胞外酶試劑
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Jan 13, 2020
Expiry Date
Jan 13, 2030
Companies making similar products

Top companies providing products similar to "Bondis Human Antistreptolysin O Set (Unsterilized)"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Bondis Human Antistreptolysin O Set (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8dfdd80abb23d42cdaba666f73b23917 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including THE BINDING SITE GROUP LIMITED, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations